If you would like to see and hear some of the experts discuss the issues surrounding gadolinium retention from gadolinium-based contrast agents, you should check out the June 2015 Radiology Podcast moderated by Herbert Y. Kressel, MD, Editor of Radiology. It can be found here – http://pubs.rsna.org/page/radiology/podcasts. You can also view it here – https://www.youtube.com/watch?v=gmgv6EvGw0o
Alexander Radbruch, MD, JD, Department of Neuroradiology, University of Heidelberg Medical Center, Heidelberg, Germany
Robert J. McDonald, MD, PhD, Department of Radiology, College of Medicine, Mayo Clinic, Rochester, Mn
Emanuel Kanal, MD, Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, Pa
Michael F. Tweedle, PhD, Department of Radiology and James Comprehensive Cancer Center, Ohio State University, Columbus, Ohio
Tomonori Kanda, MD, PhD, Department of Radiology, Teikyo University School of Medicine, Tokyo, Japan
Articles Discussed are:
Gadolinium Retention in the Dentate Nucleus and Globus Pallidus Is Dependent on the Class of Contrast Agent. Radbruch A, Weberling LD, Kieslich PJ, et al. Radiology 2015;275(3):783-791.
Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. McDonald RJ, McDonald JS, Kallmes DF, et al.Radiology 2015;275(3):772-782.
Residual or Retained Gadolinium: Practical Implications for Radiologists and Our Patients. Kanal E, Tweedle MF.Radiology 2015;275(3):630-634.
Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy. Kanda T, Fukusato T, Matsuda M, et al. Radiology 2015;276(1).